Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanni Natanegara

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Disease|February 13, 2019
First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysisLisa M Hess, Amy M DeLozier, Fanni Natanegara, et al.
The Journal of Sexual Medicine|January 20, 2007
Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the USIrwin Goldstein, Edward Kim, William D Steers, et al.
BJU International|September 13, 2005
Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trialsRidwan Shabsigh, Arthur L Burnett, Ian Eardley, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Donanemab (LY3002813) dose-escalation study in Alzheimer's diseaseStephen Loucian Lowe, Brian A Willis, Anne Hawdon, et al.
Urology|September 19, 2006
Through the eyes of women: the partners' perspective on tadalafilStanley E Althof, J Francois Eid, David R Talley, et al.
Systematic Reviews|September 18, 2014
Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerAmy M DeLozier, Jacqueline Brown, Fanni Natanegara, et al.
British Journal of Clinical Pharmacology|June 22, 2011
Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variantsRonan P Kelly, Sandra L Close, Nagy A Farid, et al.
Psychopharmacology|August 18, 2011
Effects of a novel mGlu₂/₃ receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluidStephen Lowe, Robert Dean, Bradley Ackermann, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 3, 2014
Modeling and simulations to confirm a controlled hypoglycemic stress test in healthy subjects is not associated with clinically significant QT prolongationsLai San Tham, Crystal Mei Fen Zhao, Fanni Natanegara, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2023
Decision making in clinical trials: Interim analyses, innovative design, and biomarkersKathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Disease|February 13, 2019
First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysisLisa M Hess, Amy M DeLozier, Fanni Natanegara, et al.
The Journal of Sexual Medicine|January 20, 2007
Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the USIrwin Goldstein, Edward Kim, William D Steers, et al.
BJU International|September 13, 2005
Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trialsRidwan Shabsigh, Arthur L Burnett, Ian Eardley, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Donanemab (LY3002813) dose-escalation study in Alzheimer's diseaseStephen Loucian Lowe, Brian A Willis, Anne Hawdon, et al.
Urology|September 19, 2006
Through the eyes of women: the partners' perspective on tadalafilStanley E Althof, J Francois Eid, David R Talley, et al.
Systematic Reviews|September 18, 2014
Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerAmy M DeLozier, Jacqueline Brown, Fanni Natanegara, et al.
British Journal of Clinical Pharmacology|June 22, 2011
Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variantsRonan P Kelly, Sandra L Close, Nagy A Farid, et al.
Psychopharmacology|August 18, 2011
Effects of a novel mGlu₂/₃ receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluidStephen Lowe, Robert Dean, Bradley Ackermann, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 3, 2014
Modeling and simulations to confirm a controlled hypoglycemic stress test in healthy subjects is not associated with clinically significant QT prolongationsLai San Tham, Crystal Mei Fen Zhao, Fanni Natanegara, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2023
Decision making in clinical trials: Interim analyses, innovative design, and biomarkersKathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, et al.
Pageof 3